Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
(for at least one location)
Describes the nature of a clinical study. Types include:
The purpose of this study is to develop and pilot test a culturally relevant, Facebook delivered intervention to promote smoking treatment uptake and cessation among Alaska Native (AN) smokers.
Learn more about this study.
Study statuses change often. Please contact us for help.
Contact us for the latest status
The purpose of this study is to propose a “quit for a bit” intervention to increase measurements of treatment engagement over the postoperative period (defined as the day of surgery to 30 days after surgery), and the willingness to continue treatment after this period, compared to the “quit for good” intervention.
Open for enrollment
The purpose of this study is to evaluate the feasibility of treating users of E-cigarettes with a 12-week course of varenicline to stop vaping.
Eau Claire, WI, Rochester, MN
The purpose of this trial is to assess the impact of access to technology and/or coaching support on participation in and response to a behavioral health program for smoking cessation among rural Midwest Mayo Clinic patients.
This present effort is the first step of a larger study. We are limiting the scope this AAIRB application to only the first step. The goal of the overall research study is to examine the acceptability and feasibility of using NMR to inform selection of pharmacologic treatment to increase smoking abstinence among ANAI people.
The aim of this IRB application (Aim 1a) is to refine a metabolism-informed pharmacologic intervention to optimize design and participation of a future pilot.
We will use a community-based participatory research (CBPR) approach with ANAI customer-owners, providers, and leaders to refine intervention materials and protocols used by Wells et al. for use in an ANAI clinical environment. By eliciting feedback on the acceptability and feasibility of components of the intervention through interviews, we will be able to refine the design of the intervention and future pilot.
Then, in a future AAIRB application, we will use rapid-cycle methods to beta-test the intervention with 10 customer-owners to further optimize the intervention (Aim 1b). In a third and final AAIRB application pertaining to this study, we will assess the refined intervention in a single-arm pilot (Aim 2). The current IRB application (Aim 1a) is only to conduct interviews to refine an NMR intervention and pilot design.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.